The US Food and Drug Administration has approved French pharma major Sanofi's Infilbray (venglustat), a novel, oral glucosylceramide synthase inhibitor (GCSi) that acts across the blood-brain …

Get live updates on this topic:
Silent notifications:
Interval of time threshold:
Get live updates on this topic:
Silent notifications:
Interval of time threshold:
We will only send you breaking news updates, and your own specified custom filters notifications.